Prozac Gets Conditional Clearance For Treating Children

by Medindia Content Team on  June 13, 2006 at 8:46 PM Mental Health News
RSS Email Print This Page Comment
Font : A-A+

Prozac Gets Conditional Clearance For Treating Children
Prozac has been cleared for treating children over eight years suffering from depression, but regulators have imposed strict conditions on its use.

The conditions imposed by the European licensing agency (EMEA) call for the use of the drug only when other therapies have failed. "Prozac should only be used together with psychological therapy in patients non-responding to such therapy alone after four to six sessions," said the EMEA.

Also if the child does not respond in nine weeks, it should be reconsidered. Such a move has never happened before, says Tim Kendall, joint director of the National Collaborating Centre for Mental Health. "This is the first time to my knowledge that a drug has been given a license which includes a period of psychological treatment before and during the drug treatment," he said.

The Department of Health said that anti-depressants should be rarely used in children aged 5 to 11 years, but some conditions do warrant their use, "It is important to note that some drugs which may be classified as antidepressants are used for other disorders such as nocturnal enuresis (bed-wetting), anxiety, obsessive compulsive disorder and phobic states."


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Height and Weight-Kids 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive